Flumadine is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Caraco Pharma, Inc.. The primary component is Rimantadine Hydrochloride.
| Product ID | 49708-521_3f2752c1-89c7-483d-a974-e47b75ffa259 |
| NDC | 49708-521 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Flumadine |
| Generic Name | Flumadine |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2009-09-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019649 |
| Labeler Name | Caraco Pharma, Inc. |
| Substance Name | RIMANTADINE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Influenza A M2 Protein Inhibitor [EPC],M2 Protein Inhibitors [MoA] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2018-12-31 |
| Marketing Start Date | 2009-09-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019649 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2009-09-22 |
| Marketing End Date | 2017-08-31 |
| Ingredient | Strength |
|---|---|
| RIMANTADINE HYDROCHLORIDE | 100 mg/1 |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FLUMADINE 73586285 1415548 Live/Registered |
HOFFMANN-LA ROCHE INC. 1986-03-05 |